Key result
The E98K mutation in Tpm1.1 destabilized the Tpm coiled-coil structure, increased Ca2+ sensitivity, and caused incomplete block of thin filament sliding at low Ca2+ concentrations.
Why the study?
A novel TPM1 variant (c.292G > A, p.E98K) was identified in a proband with complex cardiomyopathy, conduction dysfunction, and neuromuscular involvement, but its molecular mechanism was unknown.
The novel E98K mutation in cardiac tropomyosin impairs myocardial relaxation by destabilizing the Tpm structure and loosening its interaction with troponin I.
Should not yet guide clinical decisions; leaves open E98K relevance in human cardiomyopathy.
We characterized a novel genetic variant c.292G > A (p.E98K) in the TPM1 gene encoding cardiac tropomyosin 1.1 isoform (Tpm1.1), found in a proband with a phenotype of complex cardiomyopathy with conduction dysfunction and slow progressive neuromuscular involvement. To understand the molecular mechanism by which this mutation impairs cardiac function, we produced recombinant Tpm1.1 carrying an E98K substitution and studied how this substitution affects the structure of the Tpm1.1 molecule and its functional properties. The results showed that the E98K substitution in the N-terminal part of the Tpm molecule significantly destabilizes the C-terminal part of Tpm, thus indicating a long-distance destabilizing effect of the substitution on the Tpm coiled-coil structure. The E98K substitution did not noticeably affect Tpm’s affinity for F-actin but significantly impaired Tpm’s regulatory properties. It increased the Ca2+ sensitivity of the sliding velocity of regulated thin filaments over cardiac myosin in an in vitro motility assay and caused an incomplete block of the thin filament sliding at low Ca2+ concentrations. The incomplete motility block in the absence of Ca2+ can be explained by the loosening of the Tpm interaction with troponin I (TnI), thus increasing Tpm mobility on the surface of an actin filament that partially unlocks the myosin binding sites. This hypothesis is supported by the molecular dynamics (MD) simulation that showed that the E98 Tpm residue is involved in hydrogen bonding with the C-terminal part of TnI. Thus, the results allowed us to explain the mechanism by which the E98K Tpm mutation impairs sarcomeric function and myocardial relaxation.
No takes yet. Share an insight, caveat, or question.
Matyushenko et al. (2023) studied complex cardiomyopathy with conduction dysfunction and slow progressive neuromuscular involvement. E98K mutation in TPM1 gene was evaluated on Tpm structure and functional properties. The E98K mutation in Tpm1.1 destabilized the Tpm coiled-coil structure, increased Ca2+ sensitivity, and caused incomplete block of thin filament sliding at low Ca2+ concentrations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: